Notably, even though the most common hypothesis is that the reduced expression of p16INK4a is the leading cause of neoplastic progression, p16INK4a overexpression has been frequently found to be associated with a poor prognosis in cancer patients [1,3,12], suggesting that p16INK4a levels are tightly regulated in healthy tissues. The gene discussed is CDKN2A; the disease is cancer.